Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Jeon

Showing results (481-490 of 489) with videos related to

Pageof 49
Sort By:
You have reached the last page of results.This site can display upto 489 results.
JACC. Cardiovascular Interventions|October 25, 2011
Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) TrialDuk-Woo Park, Young-Hak Kim, Hae-Geun Song, et al.
Investigative and Clinical Urology|September 2, 2025
Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi studyJae Young Joung, In Gab Jeong, Sung Gu Kang, et al.
Clinical Therapeutics|June 8, 2026
Efficacy and Safety Profile of a Triple Single-Pill Combination of Valsartan/Amlodipine/Chlorthalidone in Patients with Uncontrolled HypertensionHae-Young Lee, Soon-Yong Suh, Ho-Joong Youn, et al.
Journal of Thoracic Disease|January 22, 2016
History of pneumonia is a strong risk factor for chronic obstructive pulmonary disease (COPD) exacerbation in South Korea: the Epidemiologic review and Prospective Observation of COPD and Health in Korea (EPOCH) studyYong Il Hwang, Sang Haak Lee, Jee Hong Yoo, et al.
Prostate International|July 7, 2025
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasiaTeak Jun Shin, Ji Yong Ha, Se Yun Kwon, et al.
Circulation|December 3, 2014
Response to letter regarding article, "optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial"Seung-Jung Park, Cheol Whan Lee, Jung-Min Ahn, et al.
Circulation|October 8, 2013
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trialCheol Whan Lee, Jung-Min Ahn, Duk-Woo Park, et al.
The New England Journal of Medicine|March 17, 2010
Duration of dual antiplatelet therapy after implantation of drug-eluting stentsSeung-Jung Park, Duk-Woo Park, Young-Hak Kim, et al.
Lancet (London, England)|April 2, 2025
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trialKi Hong Choi, Yong Hwan Park, Jong-Young Lee, et al.
Pageof 49

Showing results (481-490 of 489) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 489 results.
JACC. Cardiovascular Interventions|October 25, 2011
Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) TrialDuk-Woo Park, Young-Hak Kim, Hae-Geun Song, et al.
Investigative and Clinical Urology|September 2, 2025
Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi studyJae Young Joung, In Gab Jeong, Sung Gu Kang, et al.
Clinical Therapeutics|June 8, 2026
Efficacy and Safety Profile of a Triple Single-Pill Combination of Valsartan/Amlodipine/Chlorthalidone in Patients with Uncontrolled HypertensionHae-Young Lee, Soon-Yong Suh, Ho-Joong Youn, et al.
Journal of Thoracic Disease|January 22, 2016
History of pneumonia is a strong risk factor for chronic obstructive pulmonary disease (COPD) exacerbation in South Korea: the Epidemiologic review and Prospective Observation of COPD and Health in Korea (EPOCH) studyYong Il Hwang, Sang Haak Lee, Jee Hong Yoo, et al.
Prostate International|July 7, 2025
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasiaTeak Jun Shin, Ji Yong Ha, Se Yun Kwon, et al.
Circulation|December 3, 2014
Response to letter regarding article, "optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial"Seung-Jung Park, Cheol Whan Lee, Jung-Min Ahn, et al.
Circulation|October 8, 2013
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trialCheol Whan Lee, Jung-Min Ahn, Duk-Woo Park, et al.
The New England Journal of Medicine|March 17, 2010
Duration of dual antiplatelet therapy after implantation of drug-eluting stentsSeung-Jung Park, Duk-Woo Park, Young-Hak Kim, et al.
Lancet (London, England)|April 2, 2025
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trialKi Hong Choi, Yong Hwan Park, Jong-Young Lee, et al.
Pageof 49